Portfolio (Quarterly)
Guide ↗
Knott David M Jr
· CIK 0001892770| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GOOG | Alphabet Inc-Cl C | — | 91,420.0 | $32.3M | 17.07% | — | — | $353.33 | — |
| 2 | APOS | Apollo Global Management, Inc. | — | 225,000.0 | $26.6M | 14.07% | — | — | $118.31 | — |
| 3 | SNDX | Syndax Pharmaceutical, Inc. | Healthcare | 437,245.0 | $9.6M | 5.05% | +15K | +3.6% | $21.86 | -11.8% |
| 4 | XERS | Xeris Biopharma Holdings, Inc. | Healthcare | 1,060,000.0 | $8.4M | 4.44% | — | — | $7.92 | +6.6% |
| 5 | TVTX | Travere Therapeutics, Inc. | Healthcare | 147,282.0 | $8.4M | 4.42% | +7K | +4.7% | $56.81 | +16.7% |
| 6 | PTGX | Protagonist Therapeutics, Inc | Healthcare | 63,000.0 | $7.7M | 4.08% | — | — | $122.58 | +20.5% |
| 7 | BBIO | Bridgebio Pharma, Inc. | Healthcare | 92,850.0 | $6.9M | 3.66% | +3K | +3.2% | $74.48 | +2.8% |
| 8 | IOVA | Iovance Biotherapeutics, Inc. | Healthcare | 1,600,000.0 | $6.7M | 3.52% | — | — | $4.16 | +96.4% |
| 9 | ALKS | Alkermes PLC | Healthcare | 121,759.0 | $6.4M | 3.37% | +2K | +1.5% | $52.40 | -10.3% |
| 10 | JPM | JPMorgan Chase & Co. | Financial Services | 18,098.0 | $5.9M | 3.13% | -1K | -7.1% | $327.33 | +8.8% |
| 11 | JAAA | Janus Henderson AAA CLO ETF | — | 93,528.0 | $4.7M | 2.50% | — | — | $50.49 | +0.0% |
| 12 | — | LPL Financial Holdings Inc. | — | 16,500.0 | $4.6M | 2.46% | — | — | $281.68 | — |
| 13 | COGT | Cogent Biosciences Inc. | Healthcare | 111,081.0 | $4.3M | 2.27% | +7K | +6.8% | $38.70 | -9.6% |
| 14 | TGTX | TG Therapeutics, Inc. | Healthcare | 66,839.0 | $3.7M | 1.94% | -23K | -25.7% | $54.94 | -1.2% |
| 15 | CLST | Catalyst Pharmaceuticals, Inc. | Financial Services | 114,000.0 | $3.6M | 1.89% | NEW | — | $31.43 | -43.3% |
| 16 | AGIO | Agios Pharmaceutical, Inc. | Healthcare | 95,058.0 | $3.5M | 1.86% | +2K | +2.1% | $37.11 | -9.2% |
| 17 | VRDN | Viridian Therapeutics, Inc. | Healthcare | 181,000.0 | $3.3M | 1.76% | — | — | $18.37 | +26.1% |
| 18 | RLMD | Relmada Therapeutics, Inc. | Healthcare | 451,000.0 | $3.1M | 1.65% | +12K | +2.7% | $6.92 | -37.0% |
| 19 | RCUS | Arcus Biosciences, Inc. | Healthcare | 81,241.0 | $2.5M | 1.32% | — | — | $30.83 | -5.0% |
| 20 | HELP | Cybin Inc | Healthcare | 370,000.0 | $2.4M | 1.29% | +20K | +5.7% | $6.61 | +77.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
86.1%
Financial Services
10.0%
Technology
2.2%
Energy
0.6%
Consumer Defensive
0.4%
Real Estate
0.3%
Consumer Cyclical
0.2%
Industrials
0.2%
Basic Materials
0.1%